Medicationfollow-up in type 2 diabetes patients at a primary health care center;Seguimiento de pacientes con diabetes tipo 2 en una unidad de atención primaria de salud

Pharmaceutical Care Espana

Volumn 16, Issue 2, 2014, Pages 39-48

  Figueiredo, I V ^a   Moteiro C ^a   Castel Branco, M M ^a   Caramona, M M ^a   Fernandez Llimos, F ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Diabetes mellitus, type 2; Outcome assessment (healthcare); Pharmaceutical services

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; COMORBIDITY; CONSULTATION; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; HEALTH CENTER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERVENTION STUDY; KNOWLEDGE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIMARY HEALTH CARE; SYSTOLIC BLOOD PRESSURE;

EID: 84900432042     PISSN: None     EISSN: 11396202     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. World Health Organisation. FactSheet no312 Diabetes. 2011; Available from: http://www.who.int/mediacentre/factsheets/fs312/en/print.html [5-abril-2014]
2. Gardete Correia L, Boavida JM, Fragoso de Almeida JP, Massano Cardoso S, Dores J, Sequeira Duarte J, Duarte R, Ferreira H, Guerra F, Medina JL, Nunes JS, Pereira M, Raposo J. Diabetes: Factos e Números 2012. Lisboa: Sociedade Portuguesa de Diabetologia; 2013.
3. American Diabetes Association. Standards of medical care in diabetes - 2011. Diabetes Care. 2011 Jan; 34Suppl 1:S11-61.
4. Sociedade Portuguesa de Diabetologia. Recomendações da Sociedade Portuguesa de Diabetologia para o tratamento da Hiperglicemia e Factores de risco na Diabetes tipo 2. Revista Portuguesa de Diabetes. 2007; 2(4Suppl):5-18.
5. Melchiors AC, Correr CJ, Venson R, Pontarolo R. Ananalysis of quality of systematic reviews on pharmacist health interventions. Int J Clin Pharm. 2012 Feb; 34(1):32-42.
6. Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensivetherapy: Review and meta-analysis. Am J HealthSystPharm. 2011 Feb 1; 68(3):241-53.
7. Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med. 2011 Sep 12;171(16):1441-53.
8. Fathima M, Naik-Panvelkar P, Saini B, Armour CL. The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: a systematic review. Pharm Pract (Granada). 2013 Oct;11(4):228-45.
9. Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review. Nephrol Dial Transplant. 2012 Jan; 27(1):276-92.
10. Moullin JC, Sabater-Hernandez D, Fernandez-Llimos F, Benrimoj SI. Defining profesional pharmacy services in community pharmacy. Res Social Adm Pharm. 2013 Nov-Dec; 9(6):989-95.
11. Pharmaceutical Care Network Europe. What is Pharmaceutical Care? 2014; Available from: http://www.pcne.org/about-us.php. [5-Abril-2014]
12. Correr CJ, Melchiors AC, de Souza TT, Rotta I, Salgado TM, Fernandez-Llimos F. A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project. Ann Pharmacother. 2013 Jul-Aug; 47(7-8):946-52.
13. Benrimoj SI, Feletto E, Gastelurrutia MA, Martinez Martinez F, Faus MJ. Un enfoque holístico e integrado de la implantación de los servicios farmacéutico cognitivos. Ars Pharm. 2010; 51(2):69-87.
14. Badesso RE, Solá Uthurry NH, Armando PD. Efecto del seguimiento farmacoterapéutico a pacientes con diabetes mellitus tipo 2 en un servicio de atención primaria de Córdoba (Argentina). Pharm Care Esp. 2013; 15(1):2-9.
15. Correr CJ, Melchiors AC, Fernandez-Llimos F, Pontarolo R. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. Int J Clin Pharm. 2011 Apr; 33(2):273-80.
16. Gastelurrutia MA, Faus MJ, Fernandez-Llimos F. Providing patient care in community pharmacies in Spain. Ann Pharmacother. 2005 Dec; 39(12):2105-10. (Pubitemid 41745958)
17. Arroyo Alvarez de Toledo L, Puche Herrero M, Ramos Morales R, March Cerdá JC. Diez años de atención farmacéutica en España: explorando la realidad. Pharm Care Esp. 2011; 13(6):289-95.
18. Costa S, Santos C, Silveira J. Community pharmacy services in Portugal. Ann Pharmacother. 2006 Dec; 40(12):2228-34. (Pubitemid 44954445)
19. Cavaco AM, Cabrita J. Comment: Community pharmacy services in Portugal. Ann Pharmacother. 2007 May; 41(5):902; authorreply -3.
20. Aguas Y, Fernandez-Llimos F. Curso de iniciación al seguimiento farmacoterapéutico, 2a Ed. Redondela: CIPF; 2009.
21. Fornos JA, Andrés NF, Guerra MM. Diseño y validación de un cuestionario de conocimiento sobre diabetes en pacientes de farmacia comunitária. Pharm Care Esp. 2003; 5(6):268-74.
22. Almeida JP, Pereira MG. Questionário de Avaliação da Qualidade de Vida para adolescentes com Diabetes tipo 1: Estudo de validação do DQOL. Análise Psicológica 2008; 2(XXVI):295-307.
23. Sabater Hernandez D, Fernandez-Llimos F, Parras M, Faus MJ. Tipos de intervenciones farmacéuticas en seguimiento farmacoterapéutico. Seguimiento Farmacoterapéutico. 2005; 3(2):90-7.
24. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, BlancJJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyorala K, Raz I, Schernthaner G, Volpe M, Wood D. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. TheTask Forceon Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007 Jan; 28(1):88-136. (Pubitemid 46137814)
25. Cortez-Dias N, Martins S, Belo A, Fiuza M. Prevalence and management of hypertension in primary care in Portugal. Insights from theVALSIM study. Rev Port Cardiol. 2009 May;28(5):499-523.
26. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient out comes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007 Oct; 41(10):1569-82. (Pubitemid 47479786)
27. Correr CJ, Pontarolo R, Wiens A, Rossignoli P, Melchiors AC, Radominski R, Fernandez-Llimos F. [Economic evaluation of pharmacotherapeutic follow-up in type 2 diabetes mellitus patients in community pharmacies]. Arq Bras Endocrinol Metabol. 2009 Oct; 53(7):825-33.
28. Tan EC, Stewart K, Elliott RA, George J. Stakeholder experiences with general practice pharmacist services: a qualitative study. BMJ Open. 2013;3(9):e003214.
29. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993 Feb; 16(2):434-44. (Pubitemid 23046633)
30. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000 Aug 12; 321(7258):412-9. (Pubitemid 30609443)
31. Melchiors AC, Correr CJ, Rossignoli P, Pontarolo R, Fernandez-Llimos F. Humanistic-outcomes questionnaires in diabetes research and practice. Am J Health Syst Pharm. 2005 Feb 15; 62(4):354-5. (Pubitemid 40394610)
32. Horne R. Patients' beliefs about treatment: the hidden determinant of treatment outcome? J Psychosom Res. 1999 Dec;47(6):491-5. (Pubitemid 30029298)
33. Wong IC. Randomised controlled trials (RCTs) to evaluate complex healthcare interventions - a case study. Pharm World Sci. 2004 Oct; 26(5):247-52. (Pubitemid 39287307)